JP2008529008A5 - - Google Patents

Download PDF

Info

Publication number
JP2008529008A5
JP2008529008A5 JP2007553289A JP2007553289A JP2008529008A5 JP 2008529008 A5 JP2008529008 A5 JP 2008529008A5 JP 2007553289 A JP2007553289 A JP 2007553289A JP 2007553289 A JP2007553289 A JP 2007553289A JP 2008529008 A5 JP2008529008 A5 JP 2008529008A5
Authority
JP
Japan
Prior art keywords
cancer
cystatin
epithelial
level
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007553289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008529008A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/003049 external-priority patent/WO2006081473A2/en
Publication of JP2008529008A publication Critical patent/JP2008529008A/ja
Publication of JP2008529008A5 publication Critical patent/JP2008529008A5/ja
Pending legal-status Critical Current

Links

JP2007553289A 2005-01-28 2006-01-30 上皮癌の診断および予後診断のための方法 Pending JP2008529008A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64811005P 2005-01-28 2005-01-28
PCT/US2006/003049 WO2006081473A2 (en) 2005-01-28 2006-01-30 Methods for diagnosis and prognosis of epithelial cancers

Publications (2)

Publication Number Publication Date
JP2008529008A JP2008529008A (ja) 2008-07-31
JP2008529008A5 true JP2008529008A5 (enExample) 2009-03-19

Family

ID=36741098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007553289A Pending JP2008529008A (ja) 2005-01-28 2006-01-30 上皮癌の診断および予後診断のための方法

Country Status (9)

Country Link
US (7) US8685659B2 (enExample)
EP (1) EP1842065B1 (enExample)
JP (1) JP2008529008A (enExample)
CN (1) CN101268368A (enExample)
AT (1) ATE490465T1 (enExample)
AU (1) AU2006207954A1 (enExample)
CA (1) CA2595377A1 (enExample)
DE (1) DE602006018578D1 (enExample)
WO (1) WO2006081473A2 (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100022414A1 (en) 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
EP1512970A1 (en) * 2003-09-05 2005-03-09 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for determining the impact of a multicomponent mixture on the biological profile of a disease
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
AU2006207954A1 (en) * 2005-01-28 2006-08-03 Childrens Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
EP1984738A2 (en) 2006-01-11 2008-10-29 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
EP4190448A3 (en) 2006-05-11 2023-09-20 Bio-Rad Laboratories, Inc. Microfluidic devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US9012390B2 (en) 2006-08-07 2015-04-21 Raindance Technologies, Inc. Fluorocarbon emulsion stabilizing surfactants
KR100767878B1 (ko) * 2006-11-07 2007-10-17 전북대학교산학협력단 간세포암 진단용 조성물, 이를 포함하는 간세포암 진단키트 및 간세포암 진단방법
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
CA2679205A1 (en) * 2007-02-23 2008-08-28 Predictive Biosciences Corporation Clinical intervention directed diagnostic methods
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2009017475A1 (en) * 2007-07-27 2009-02-05 Children's Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
JP5120843B2 (ja) * 2008-06-04 2013-01-16 国立大学法人山梨大学 自己免疫性膵炎の検査方法及び検査試薬
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
EP2486409A1 (en) 2009-10-09 2012-08-15 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP4435111A1 (en) 2010-02-12 2024-09-25 Bio-Rad Laboratories, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
CA3067107C (en) * 2010-06-03 2022-07-12 Idexx Laboratories, Inc. Markers for renal disease
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
US9364803B2 (en) 2011-02-11 2016-06-14 Raindance Technologies, Inc. Methods for forming mixed droplets
EP2675819B1 (en) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
WO2012167142A2 (en) 2011-06-02 2012-12-06 Raindance Technolgies, Inc. Enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US20130115599A1 (en) * 2011-11-08 2013-05-09 Medical Diagnostic Laboratories, Llc Increased cip2a expression and bladder cancer in humans
EP2823303A4 (en) 2012-02-10 2015-09-30 Raindance Technologies Inc MOLECULAR DIAGNOSTIC SCREENING TEST
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
CN104981696B (zh) * 2012-12-11 2017-11-24 康奈尔大学 诊断和治疗前列腺癌的方法
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
US10712349B2 (en) 2014-04-15 2020-07-14 The Brigham And Women's Hospital, Inc. Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney
GB201501930D0 (en) 2015-02-05 2015-03-25 Univ London Queen Mary Biomarkers for pancreatic cancer
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
CN108700600B (zh) 2016-03-02 2022-06-03 艾德克斯实验室公司 用于检测和诊断肾病和牙周病的方法和组合物
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
US20230314408A1 (en) * 2020-07-02 2023-10-05 Gopath Laboratories Llc Immune profiling and methods of using same to predict responsiveness to an immunotherapy and treat cancer
CN112379093B (zh) * 2020-10-22 2023-06-16 上海良润生物医药科技有限公司 CST-Cathepsin复合物作为肿瘤诊断标志物的应用
CN119604763A (zh) * 2022-01-26 2025-03-11 艾德克斯实验室公司 用于区分进展性慢性肾脏疾病与稳定性慢性肾脏疾病的方法和组合物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
US5045694A (en) 1989-09-27 1991-09-03 The Rockefeller University Instrument and method for the laser desorption of ions in mass spectrometry
EP1347493A3 (en) 1993-05-28 2005-11-23 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
US5702892A (en) 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
ES2390530T3 (es) 1996-07-15 2012-11-13 The Regents Of The University Of California Genes procedentes del amplicón 20Q13 y sus usos
JPH10262680A (ja) 1997-03-25 1998-10-06 Kirin Brewery Co Ltd Ｒｈｏ標的タンパク質ヒトｍＤｉａおよびその遺伝子
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6642007B1 (en) 1998-11-02 2003-11-04 Pfizer Inc. Assays for measurement of type II collagen fragments in urine
US20030124543A1 (en) 1999-01-15 2003-07-03 Stuart Susan G. Breast cancer marker
US6358683B1 (en) 1999-06-03 2002-03-19 The Regents Of The University Of California Blood-based assays for breast cancer
US6939714B2 (en) * 1999-06-18 2005-09-06 Biotherapies, Inc. Epithelial cell growth inhibitors
WO2001018058A2 (en) 1999-09-07 2001-03-15 Viventia Biotech Inc. Enhanced phage display library of human vh fragments and methods for producing same
US6998232B1 (en) * 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
US20040142361A1 (en) * 1999-11-30 2004-07-22 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7429466B2 (en) 2000-01-24 2008-09-30 Hypromatrix, Inc Methods and arrays for detecting biological molecules
US20030077616A1 (en) 2001-04-19 2003-04-24 Ciphergen Biosystems, Inc. Biomolecule characterization using mass spectrometry and affinity tags
US7112408B2 (en) 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
US20040076955A1 (en) * 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
US20030013208A1 (en) 2001-07-13 2003-01-16 Milagen, Inc. Information enhanced antibody arrays
EP1425695A2 (en) 2001-08-13 2004-06-09 Beyong Genomics, Inc. Method and system for profiling biological systems
US20040009212A1 (en) 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
US20030157579A1 (en) * 2002-02-14 2003-08-21 Kalobios, Inc. Molecular sensors activated by disinhibition
AU2003239152A1 (en) 2002-04-23 2003-11-10 Millipore Corporation Sample preparation of biological fluids for proteomic applications
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
EP1608255A4 (en) 2003-04-01 2008-06-25 Univ Johns Hopkins Med ENDOTHELIAL CELL EXPRESSION PATTERN IN CHEST
AU2006207954A1 (en) * 2005-01-28 2006-08-03 Childrens Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers
WO2009017475A1 (en) 2007-07-27 2009-02-05 Children's Medical Center Corporation Methods for diagnosis and prognosis of epithelial cancers

Similar Documents

Publication Publication Date Title
JP2008529008A5 (enExample)
JP2008530582A5 (enExample)
JP2008536098A5 (enExample)
Jozghorbani et al. Determination of carcinoembryonic antigen as a tumor marker using a novel graphene-based label-free electrochemical immunosensor
Best et al. GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis
Gao et al. Multiplexed detection of lung cancer biomarkers in patients serum with CMOS-compatible silicon nanowire arrays
Nesterova et al. Autoantibody biomarker opens a new gateway for cancer diagnosis
Soler et al. Label-free SPR detection of gluten peptides in urine for non-invasive celiac disease follow-up
Zhu et al. Using a glucose meter to quantitatively detect disease biomarkers through a universal nanozyme integrated lateral fluidic sensing platform
WO2010038974A3 (ko) 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트
US20180080937A1 (en) Biomarker Panel For Diagnosing Cancer
WO2017107974A1 (zh) 血清psmd4蛋白的检测试剂盒及其检测方法与应用
JP2014531573A5 (enExample)
NO20076656L (no) Forbedrede immunoassay metoder
JP2010509570A5 (enExample)
JP2011506941A5 (enExample)
Bertok et al. Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core
ES2527830T3 (es) Método para detectar el cáncer de páncreas mediante el marcador serológico ULBP2
JP2018533724A (ja) 肝細胞癌および膵臓がんを診断するためのラミニン２の使用
Ranjan et al. Scope of biosensors, commercial aspects, and miniaturized devices for point-of-care testing from lab to clinics applications
US20250035633A1 (en) Compositions and methods for detecting cadherin-17 protein
JP2024059621A (ja) がんの診断及び治療のための組成物及び方法
Hsu et al. Instrument-free detection of FXYD3 using vial-based immunosensor for earlier and faster urothelial carcinoma diagnosis
JP2016519767A5 (enExample)
JP2012531612A5 (enExample)